http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005350394-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4c2477bdea308bc9dec3feded37457 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a177f0fa84b1b2134e13caa36974ce3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 2004-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1ac28296806fdb8f6b5a2cea41197b7 |
| publicationDate | 2005-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2005350394-A |
| titleOfInvention | Sepsis treatment |
| abstract | The present invention provides a therapeutic agent for sepsis. SOLUTION: General formula (I) [Chemical 1] (In the formula, PY is a pyridinyl group or a condensed pyridinyl group optionally substituted by one or two lower alkyl groups, R 1 is a hydrogen atom or a lower alkyl group, and R 2 is a hydrogen atom or lower group. An alkyl group, and Q is a nitro group, a cyano group, a hydrogen atom, a carbamyl group, a halogen atom or an amino group)), a pharmacologically acceptable salt thereof, or a pharmaceutically acceptable salt thereof A therapeutic agent for sepsis, comprising as an active ingredient a solvate. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102949355-A |
| priorityDate | 2004-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.